Inventor · disambiguated record
Pedro Alzari
Also filed as: ALZARI PEDRO · ALZARI PEDRO M
12 granted patents·8 pending applications·45 citations·filing 1999–2020
88Inventor score
Top patents by PatentIndex Score
20 records- 0190US7101965B2Peptides of IL-2PASTEUR INSTITUT·Filed 2003·Granted Sep 5, 2006·20 cites·24 claims
- 0287US9422548B2OB-fold used as scaffold for engineering new specific bindersPASTEUR INSTITUT·Filed 2015·Granted Aug 23, 2016·5 cites·13 claims
- 0376US6929791B2Peptides of IL-2 and derivatives thereofPASTEUR INSTITUT·Filed 2001·Granted Aug 16, 2005·6 cites·20 claims
- 0475US7662368B2Method of inducing SHC phosphorylation of inducing the SHC/MAPK pathway by administering a peptide of IL-2PASTEUR INSTITUT·Filed 2006·Granted Feb 16, 2010·2 cites·17 claims
- 0569US7704490B2Method for inducing selected useful activities of IL-2 in a patient with peptides from IL-2PASTEUR INSTITUT·Filed 2005·Granted Apr 27, 2010·2 cites·23 claims
- 0667US11434585B2OB-fold used as scaffold for engineering new specific bindersPASTEUR INSTITUT·Filed 2020·Granted Sep 6, 2022·0 cites·20 claims
- 0764US8099245B2Crystallographic structure of Trypanosoma cruzi proline racemase and uses thereforMINOPRIO PAOLA·Filed 2004·Granted Jan 17, 2012·4 cites·24 claims
- 0860US2010145008A1Ob-fold used as scaffold for engineering new specific bindersPASTEUR INSTITUT·Filed 2007·Application pending·0 cites
- 0958US10584330B2OB-fold used as scaffold for engineering new specific bindersPASTEUR INSTITUT·Filed 2016·Granted Mar 10, 2020·0 cites·12 claims
- 1055US2007128678A1Pknb kinase and pstp phosphatase and methods of identifying inhibitory substancesPASTEUR INSTITUT·Filed 2004·Application pending·0 cites
- 1154US6825334B1Peptides of IL-2 and derivatives thereof and their use as therapeutic agentsPASTEUR INSTITUT·Filed 1999·Granted Nov 30, 2004·6 cites·8 claims
- 1251US2010183645A1Active or passive immunization against proapoptotic neurotrophins for the treatment and/or prevention of neurodegenerative diseasesPASTEUR INSTITUT·Filed 2009·Application pending·0 cites
- 1348US2013143201A1Crystallographic structure of TcPRACA and uses thereforMINOPRIO PAOLA·Filed 2009·Application pending·0 cites
- 1447US7585656B2Crystallographic structure of TcPRACA and uses thereforPASTEUR INSTITUT·Filed 2004·Granted Sep 8, 2009·0 cites·8 claims
- 1546US7364856B2PknB kinase and pstP phosphatase and methods of identifying inhibitory substancesPASTEUR INSTITUT·Filed 2005·Granted Apr 29, 2008·0 cites·12 claims
- 1645US2010273723A1Peptides of il-2PASTEUR INSTITUT·Filed 2010·Application pending·0 cites
- 1744US9328163B2Post-translationally modified neurotrophin antibodiesPASTEUR INSTITUT·Filed 2013·Granted May 3, 2016·0 cites·12 claims
- 1843US2004106119A1Crystal structure of the mouse apoptosis-inducing factor AIF and applications of such structural data to structure-based identification, screening, or design of AIF agonists or antagonists as well as AIF fragments, mutants or variantsFiled 2003·Application pending·0 cites
- 1941US2010055109A1Post-translationally modified neurotrophinsPASTEUR INSTITUT·Filed 2007·Application pending·0 cites
- 2038US2006275290A1Active or passive immunization against proapoptotic neurotrophins for the treatment and/or prevention of neurodegenerative diseasesINST DE INVEST BIO CLEMENTE ES·Filed 2006·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →